	Ebit		Date
Acadia Pharmaceuticals	USD 35.76M	3.38M	2025-09
Adma Biologics	USD 49.19M	7.26M	2025-09
ALKERMES	USD 89.08M	3.9M	2025-09
Alterity Therapeutics Limited	AUD -7.77M	2.99M	2023-06
AstraZeneca	USD 2.97B	4.48B	2025-12
BioCryst Pharmaceuticals	USD -4.51M	12.2M	2024-12
Bristol-Myers Squibb	USD 3.47B	567M	2025-12
Cipla	INR 9.77B	6.21B	2025-12
Clal Biotechnology	ILS -5.44M	3.76M	2022-12
Compugen	USD -7.89M	536K	2025-09
CSL	USD 2.75B	1.35B	2024-12
Dynavax Technologies	USD 21.27M	10.41M	2025-09
Eli Lilly	USD 8.99B	1.57B	2025-12
Esperion Therapeutics	USD -16.03M	11.51M	2024-09
GlaxoSmithKline	GBP 1.44B	1.35B	2025-12
Grifols	EUR 411.56M	15.51M	2025-09
Halozyme Therapeutics	USD 217.92M	15.48M	2025-09
Ionis Pharmaceuticals	USD -160.18M	304.96M	2025-09
J&J	USD 5.11B	2.3B	2025-12
Merck	USD 6.24B	1.32B	2025-12
Minerva Neurosciences	USD -4.37M	1.71M	2024-09
Neurocrine Biosciences	USD 239.3M	93.7M	2025-09
Novartis	USD -9.19B	13.87B	2025-06
Novavax	USD -134.02M	49.55M	2024-09
Pfizer	USD 4.65B	71M	2025-12
Roche Holding	CHF 9.56B	2.1B	2025-12
Sanofi	EUR 1.7B	2.17B	2025-12
Takeda	JPY 257.49B	568.56B	2025-12
Vanda Pharmaceuticals	USD -10.28M	721K	2024-12

Minerva Neurosciences - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.